Speeding Myeloma Research

myelomaMinBannerTemplate3.15.png

| INNOVATION | Latest Research

asiaglobe.png

How the Asia-Pacific Region Is Bolstering Myeloma Research: Report from Tokyo

In his blog from Tokyo, IMF Chairman Dr. Brian G.M. Durie notes that the Asia-Pacific region is home to approximately 60 percent of all myeloma patients. “What is learned in Asia can be used to enhance understanding and treatment worldwide,” he says. “And with rapid clinical trial accrual in Asia, there is the potential for fast progress.”

LearnMoreButton.png

| INNOVATION | Drug News

490x245 fda.png

FDA Approves a Fifth Indication for the Use of Darzalex (daratumumab) in the US

On May 7, 2018, the FDA granted approval for use of Darzalex® (daratumumab) in combination with Velcade®, melphalan, and prednisone (VMP) for the treatment of newly diagnosed patients with multiple myeloma who are ineligible for autologous stem cell transplantation. This is the fifth indication for Darzalex in the U.S.

LearnMoreButton.png

| INSPIRATION | Mother's Day

AmazonMothersDay200x200.png

| EDUCATION | Event

200x200 indy.png

Shop Amazon This Mother’s Day and Give to the IMF at the Same Time

Regional Community Workshop in Indianapolis

Whether you shop Amazon this Mother’s Day (Sunday, May 13th) or for your daily needs, please bookmark amazon.myeloma.org. When you shop at this link, Amazon will donate a percentage of your total purchase to the IMF, at no added cost to you. Donating to the IMF this Mother’s Day is as easy as a point-and-click.

The IMF will host a Regional Community Workshop in Indianapolis, IN, on Saturday June 9, 2018. Registration is FREE, but seating is limited. Here’s your chance to learn from and meet one-on-one with myeloma experts Rafat Abonour, MD (Indiana University, Indianapolis, IN), Al-Ola A Abdallah, MD (Assistant Professor, Univ. of Kansas Medical Center, Kansas, KS), and Kimberly Odgers Noonan, RN, ANP, AOCN (Dana-Farber Cancer Institute, Boston, MA).

ShopNowButton.png

registerNowButton.png

| EDUCATION | Oncology Nursing

490x245 ons.png

Register NOW for the IMF-Sponsored Satellite Symposium at the Oncology Nursing Society's 43rd Annual Congress

The IMF-sponsored satellite symposium, "Myeloma Case Studies: Evolving Paradigms in Nursing Care," will take place at the Oncology Nursing Society’s 43rd Annual Congress in Washington, DC, at the Washington Marriott Marquis (Marquis Ballroom 6-10) from 12:15 to 1:45 p.m. on Thursday, May 17, 2018. This engaging case-based 1.5 CNE learning opportunity is intended for oncology nurses who care for multiple myeloma patients.

registerNowButton.png

| INNOVATION | Research Grant

490x245 advocacy.png

Calling All Myeloma Researchers: CDMRP Research Funding Applications Now Live

Fiscal year 2018 Congressionally Directed Medical Research Programs (CDMRP) research funding applications are now available. Thanks to the inclusion of myeloma and all blood cancers for this fiscal year, myeloma researchers are eligible to apply for these funds. Learn about these CDMRP funding opportunities and how to apply. Please note that submission is a two-step process and pre-applications are required for these grants. Pre-applications are due on June 20, 2018, and full applications are due on September 26, 2018. If you need assistance with the application, or to find out more about the CDMRP program, contact advocacy@myeloma.org.

LearnMoreButton.png

| EMPOWERMENT | International

490x245 nadia.png

IMF Patient & Family Seminar in Finland

An IMF doctors’ meeting in collaboration with Suomen Syöpäpotilaat ry, the Finnish Cancer Patient Association, took place for the first time on April 27, 2018, in Helsinki, Finland. Moderated by the International Myeloma Working Group member Dr. Raija Silvennoien, the meeting included many Finnish myeloma doctors. Guest speakers were Dr. Sundar Jagannath (Mount Sinai — New York) who presented on CAR T-cell therapy, Dr. Caroline Heckman (Finnish Institute for Molecular Medicine), and Muntasir Majumder (Finnish Institute for Molecular Medicine).

LearnMoreButton.png

| #ASKDRDURIE | Dr. Durie's Weekly Web Video Series

DurieVideoBox5.10.png

CLINICAL TRIALS

EVENTS

BOSTON Trial Fact Sheet

New isatuximab Clinical Trial: the IMROZ Study

New isatuximab Clinical Trial: the IKEMA Study

New ixazomib Clinical Trials: Learn How to Participate

Join the conversation about myeloma on the Smart Patients Message Board

May 12, 2018
IMF Regional Community Workshop
Seattle, WA

June 2, 2018
11th Annual Carolyn Czerkies Memorial Golf Outing
Joliet, IL

June 9, 2018
IMF Regional Community Workshop
Indianapolis, IN

August 24-25, 2018
IMF Patient & Family Seminar
Los Angeles, CA

subscribe_button.png          donate_button_bottom.png
We Thank Our Sponsors:
Amgen, Celgene Corporation, Genentech, Janssen Oncology, and Takeda Oncology
and individuals like you who supported the IMF this year